GRB7 is required for triple-negative breast cancer cell invasion and survival

Breast Cancer Research and Treatment

Volumn 133, Issue 2, 2012, Pages 607-615

  Giricz, Orsi ^a   Calvo, Verónica ^a   Pero, Stephanie C ^b   Krag, David N ^b   Sparano, Joseph A ^a,c   Kenny, Paraic A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Adapter proteins; GRB7; Receptor tyrosine kinase signaling; Triple negative breast cancer; Tumor cell invasion

Indexed keywords

ANTHRACYCLINE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 7; PROTEIN SH2; TAXANE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER SURVIVAL; CELL MOTILITY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GRB7 GENE; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER;

APOPTOSIS; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FEMALE; GRB7 ADAPTOR PROTEIN; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS, BASAL CELL; PEPTIDES, CYCLIC; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS;

EID: 84863724949     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1822-6     Document Type: Article

References (35)

1. Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363:1938-1948. doi:10.1056/NEJMra1001389
2. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC (2009) Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7:122-192
3. Sparano JA, Goldstein L, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman L, Martino S, Davidson NE, Kenny PA, Sledge GW, Jr., Gray R (2011) Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple negative breast cancer. Clin Cancer Res. doi:10.1158/1078-0432.CCR-10-3357
4. Han DC, Shen TL, Guan JL (2001) The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene 20:6315-6321. doi:10.1038/sj.onc.1204775
5. Shen TL, Guan JL (2004) Grb7 in intracellular signaling and its role in cell regulation. Front Biosci 9:192-200
6. Chu PY, Li TK, Ding ST, Lai IR, Shen TL (2010) EGF-induced Grb7 recruits and promotes Ras activity essential for the tumor-igenicity of Sk-Br3 breast cancer cells. J Biol Chem 285:29279-29285. doi:10.1074/jbc.C110.114124
7. Bai T, Luoh SW (2008) GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation. Carcinogenesis 29:473-479. doi:10.1093/carcin/bgm221
8. Siamakpour-Reihani S, Argiros HJ, Wilmeth LJ, Haas LL, Peterson TA, Johnson DL, Shuster CB, Lyons BA (2009) The cell migration protein Grb7 associates with transcriptional regulator FHL2 in a Grb7 phosphorylation- dependent manner. J Mol Recognit 22:9-17. doi:10.1002/jmr.916
9. Pero SC, Oligino L, Daly RJ, Soden AL, Liu C, Roller PP, Li P, Krag DN (2002) Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7. J Biol Chem 277:11918-11926. doi:10.1074/jbc.M111816200
10. Tanaka S, Pero SC, Taguchi K, Shimada M, Mori M, Krag DN, Arii S (2006) Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst 98:491-498. doi:10.1093/jnci/djj105
11. Deshayes S, Morris MC, Divita G, Heitz F (2005) Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci 62:1839-1849. doi:10.1007/s00018-005-5109-0
12. Briand P, Petersen OW, Van Deurs B (1987) A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol 23:181-188
13. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH, Petersen OW, Gray JW, Bissell MJ (2007) The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 1:84-96
14. Moyret C, Madsen MW, Cooke J, Briand P, Theillet C (1994) Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522. Exp Cell Res 215:380-385. doi:10.1006/excr.1994.1355
15. Lee GY, Kenny PA, Lee EH, Bissell MJ (2007) Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4:359-365
16. Stein D, Wu J, Fuqua S, Roonprapunt C, Yajnik V, D'Eustachio P, Moskow J, Buchberg A, Osborne C, Margolis B (1994) The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J 13:1331-1340
17. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, Devries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527
18. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO (2007) Prognostic markers in triple-negative breast cancer. Cancer 109:25-32
19. Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Janne PA (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316:1039-1043. doi:10.1126/science.1141478
20. Nadler Y, Gonzalez AM, Camp RL, Rimm DL, Kluger HM, Kluger Y (2010) Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer. Ann Oncol 21:466-473. doi:10.1093/annonc/ mdp346
21. Nencioni A, Cea M, Garuti A, Passalacqua M, Raffaghello L, Soncini D, Moran E, Zoppoli G, Pistoia V, Patrone F, Ballestrero A (2010) Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression. PLoS ONE 5:e9024. doi:10.1371/journal.pone. 0009024
22. Ramsey B, Bai T, Hanlon Newell A, Troxell M, Park B, Olson S, Keenan E, Luoh SW (2010) GRB7 protein over-expression and clinical outcome in breast cancer. Breast Cancer Res Treat. doi: 10.1007/s10549-010-1010-0
23. van Agthoven T, Veldscholte J, Smid M, van Agthoven TL, Vreede L, Broertjes M, de Vries I, de Jong D, Sarwari R, Dors-sers LC (2009) Functional identification of genes causing estrogen independence of human breast cancer cells. Breast Cancer Res Treat 114:23-30. doi:10.1007/s10549-008-9969-5
24. van Agthoven T, Sieuwerts AM, Meijer-van Gelder ME, Look MP, Smid M, Veldscholte J, Sleijfer S, Foekens JA, Dorssers LC (2009) Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance. J Clin Oncol 27:542-549. doi:10.1200/JCO.2008.17.1462
25. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817-2826
26. Maqani N, Belkhiri A, Moskaluk C, Knuutila S, Dar AA, El-Rifai W (2006) Molecular dissection of 17q12 amplicon in upper gastrointestinal adenocarcinomas. Mol Cancer Res 4:449-455. doi:10.1158/1541-7786.MCR-06-0058
27. McIntyre A, Summersgill B, Spendlove HE, Huddart R, Houlston R, Shipley J (2005) Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors. Neoplasia 7:1047-1052
28. Haran M, Chebatco S, Flaishon L, Lantner F, Harpaz N, Valinsky L, Berrebi A, Shachar I (2004) Grb7 expression and cellular migration in chronic lymphocytic leukemia: a comparative study of early and advanced stage disease. Leukemia 18:1948-1950. doi:10.1038/sj.leu.2403512
29. Ambaye ND, Gunzburg MJ, Lim RC, Price JT, Wilce MC, Wilce JA (2010) Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists. Bioorg Med Chem. doi:10.1016/j.bmc.2010.10.030
30. Yap MY, Wilce MC, Clayton DJ, Perlmutter P, Aguilar MI, Wilce JA (2010) Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide. Acta Crystallogr Sect F Struct Biol Cryst Commun 66:1640-1643. doi:10.1107/S1744309110041850
31. Verbeek BS, Adriaansen-Slot SS, Rijksen G, Vroom TM (1997) Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol 183:195-203. doi:10.1002/(SICI)1096-9896(199710)183:2\195:AID-PATH901 [3.0.CO;2-Y
32. Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z, Moran MF, Oshima RG, Cardiff RD, Muller WJ (2001) Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol 21:1540-1551. doi:10.1128/MCB.21. 5.1540-1551.2001
33. Ajiro M, Nishidate T, Katagiri T, Nakamura Y (2010) Critical involvement of RQCD1 in the EGFR-Akt pathway in mammary carcinogenesis. Int J Oncol 37:1085-1093
34. Cailliau K, Perdereau D, Lescuyer A, Chen H, Garbay C, Vilain JP, Burnol AF, Browaeys-Poly E (2005) FGF receptor phos-photyrosine 766 is a target for Grb14 to inhibit MDA-MB-231 human breast cancer cell signaling. Anticancer Res 25:3877-3882
35. Kairouz R, Parmar J, Lyons RJ, Swarbrick A, Musgrove EA, Daly RJ (2005) Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells. J Cell Physiol 203:85-93. doi:10.1002/jcp.20199